AI biotech Iambic raises $100M from ARK, Regeneronnews2025-11-10T12:00:53+00:00November 10th, 2025|Endpoints News|
#AASLD25: Vir presents new hepatitis D data and ramps up bullish Phase 3 plansnews2025-11-09T23:15:42+00:00November 9th, 2025|Endpoints News|
#AHA25: Merck reports pivotal PCSK9 pill data in race to beat AstraZeneca to marketnews2025-11-09T22:00:40+00:00November 9th, 2025|Endpoints News|
#AHA25: Amgen’s cholesterol drug cuts first-time cardiovascular events by a quarternews2025-11-08T15:10:59+00:00November 8th, 2025|Endpoints News|
White House unveils MFN deals; Metsera saga ends; Q3 earnings updates; and morenews2025-11-08T11:00:57+00:00November 8th, 2025|Endpoints News|
Updated: Pfizer triumphs over Novo Nordisk with $10B bid for Metseranews2025-11-08T09:36:54+00:00November 8th, 2025|Endpoints News|
CMS unveils new Medicaid drug payment modelnews2025-11-07T20:56:28+00:00November 7th, 2025|Endpoints News|
FDA says it raised concerns about Biohaven’s ataxia study several times since it was proposednews2025-11-07T20:08:07+00:00November 7th, 2025|Endpoints News|
Gilead’s Trodelvy fails Phase 3 breast cancer studynews2025-11-07T20:02:05+00:00November 7th, 2025|Endpoints News|
#SITC25: Akeso, Summit’s PD-1xVEGF drug extends life in China lung cancer studynews2025-11-07T16:30:31+00:00November 7th, 2025|Endpoints News|
